Skip to main content
. 2024 Jun 26;12(7):713. doi: 10.3390/vaccines12070713

Table 3.

Impact of Variables.

Variable Effect Magnitude p-Value Confidence Interval
Sex * 0.111 0.270 −0.086 to 0.309
Smoking history −0.191 0.089 −4.110 to 0.029
Ethnicity
(Black vs. White)
0.090 0.308 −0.830 to 0.264
Ethnicity
(All other vs. White)
0.117 0.233 0.075 to 0.309
Cancer stage
(III/IV vs. I/II)
−0.154 0.090 −0.333 to 0.024
Histology
(adeno vs. non)
−0.057 0.619 −0.280 to 0.166
Steroid use −0.248 0.043 −0.488 to −0.008
Chemotherapy −0.186 0.033 −0.358 to −0.015
Targeted Therapy −0.113 0.347 −0.350 to 0.123
Immune therapy −0.009 0.912 −0.165 to 0.148
Influenza vax 0.330 <0.001 0.150 to 0.509
SARS-CoV-2 booster 0.412 <0.001 0.291 to 0.534
SARS-CoV-2 infection 0.276 <0.001 0.128 to 0.425

Negative effects (those associated with decreased titers) are indicated in red. Significant findings are bolded. * Nonlinear effects of “Time after full vaccination” and “Age” on titers are shown in Supplemental Table S3.